Literature DB >> 809683

[Penicillin V potassium in tonsillar tissue and serum (author's transl)].

H Backmann, H Drees, D Geisen, K Mündnich, W Ritzerfeld.   

Abstract

1.2 mega U Penicillin V potassium was given to 20 patients 2 hours (group 1) and another 19 patients 3 hours (group 2) before tonsillectomy. After the operation biological determinations of the levels of active principle were made from tonsillar tissue and serum with statistical evaluation of the results (Spearman's rank correlation). There was a significant connection between the serum and tonsillar tissue concentrations (in children and adults) in both groups. The level of the active principle in group 2 was only slightly lower than in group 1. Many of the micro-organisms responsible for tonsillitis can be influenced by the concentrations found here, so that application of Penicillin V can often be expected to have a good therapeutic effect.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 809683

Source DB:  PubMed          Journal:  MMW Munch Med Wochenschr        ISSN: 0341-3098


  4 in total

1.  [Concentrations in serum and tonsils after infection of azidocillin (author's transl)].

Authors:  T Brusis; D Förster; H J Grofe; H Weuta
Journal:  Infection       Date:  1977       Impact factor: 3.553

2.  Ciprofloxacin concentrations in tonsils following single or multiple administrations.

Authors:  N Falser; A Dalhoff; H Weuta
Journal:  Infection       Date:  1988       Impact factor: 3.553

3.  Group B streptococcal pharyngitis in the compromised adult: therapeutic considerations.

Authors:  M L Corrado; D J Palmadessa; S H Corrado; C Weissman; C E Cherubin; S H Landesman
Journal:  J Natl Med Assoc       Date:  1981-10       Impact factor: 1.798

4.  [Experience with cefaclor in the treatment of ear, nose and throat infections. Indications for cefaclor therapy (author's transl)].

Authors:  P Federspil; R Bach; C Weich; H J Wilhelm; E Tiesler; W Schätzle
Journal:  Infection       Date:  1979       Impact factor: 3.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.